Advertisement

Miller Fisher Syndrome

  • An-Guor Wang
Chapter

Abstract

A 12-year-old boy presented with complaints of sudden-onset diplopia noted in the morning starting 3 days ago. One month ago, he had an episode of dizziness, chest tightness, and a common cold which resolved spontaneously. He denied any past medical history of head injury or epistaxis. Visual acuity was 6/6 in both eyes. A Hirschberg test showed a 5° esotropia on primary gaze. A prism cover test revealed 25 prism diopters of esotropia on primary gaze, which decreased to 18 on right gaze and increased to 40 on left gaze. Extraocular movements showed mild limitation of abduction in right gaze (−1 OD) and moderate limitation in left gaze (−2 OS) (Fig. 36.1). Anterior segments, pupillary reflexes, and fundoscopic examinations were normal. He received a brain CT scan which was also normal. One week later, he developed bilateral ptosis and total ophthalmoplegia (Fig. 36.2). A neostigmine test by intramuscular injection was performed in-office. However, no improvement in lid position or extraocular movement was observed. Thus, he was admitted for further investigation.

References

  1. 1.
    Bukhari S, Taboada J. A case of Miller Fisher syndrome and literature review. Cureus. 2017;9(2):e1048.PubMedPubMedCentralGoogle Scholar
  2. 2.
    Mori M, Kuwabara S, Fukutake T, et al. Clinical features and prognosis of Miller Fisher syndrome. Neurology. 2001;56(8):1104–6.CrossRefPubMedGoogle Scholar
  3. 3.
    Lo YL. Clinical and immunological spectrum of the Miller Fisher syndrome. Muscle Nerve. 2007;36:615–27.CrossRefPubMedGoogle Scholar
  4. 4.
    Yuki N. Molecular mimicry between gangliosides and lipopolysaccharides of Campylobacter jejuni isolated from patients with Guillain Barré syndrome and Miller Fisher syndrome. J Infect Dis. 1997;176(Suppl 2):S150–3.CrossRefPubMedGoogle Scholar
  5. 5.
    Yuki N, Taki T, Takahashi M, et al. Molecular mimicry between GQ1b ganglioside and lipopolysaccharides of Campylobacter jejuni isolated from patients with Fischer’s syndrome. Ann Neurol. 1994;36:791–3.CrossRefPubMedGoogle Scholar
  6. 6.
    Chiba A, Kusunoki S, Obata H, Machinami R, Kanazawa I. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barre syndrome: clinical and immunohistochemical studies. Neurology. 1993;43:1911–7.CrossRefPubMedGoogle Scholar
  7. 7.
    Chiba A, Kusunoki S, Shimizu T, Kanazawa I. Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. Ann Neurol. 1992;31:677–9.CrossRefPubMedGoogle Scholar
  8. 8.
    Kusunoki S, Chiba A, Kanazawa I. Anti-GQ1b IgG antibody is associated with ataxia as well as ophthalmoplegia. Muscle Nerve. 1999;22:1071–4.CrossRefPubMedGoogle Scholar
  9. 9.
    al-Din SN, Anderson M, Eeg-Olofsson O, Trontelj JV. Neuro-ophthalmic manifestations of the syndrome of ophthalmoplegia, ataxia and areflexia: a review. Acta Neurol Scand. 1994;89(3):157–63.CrossRefPubMedGoogle Scholar
  10. 10.
    Keane JR, Finstead BA. Upward gaze paralysis as the initial sign of Fisher’s syndrome. Arch Neurol. 1982;39(12):781–2.CrossRefPubMedGoogle Scholar
  11. 11.
    Caccavale A, Mignemi L. Acute onset of a bilateral areflexical mydriasis in Miller-Fisher syndrome: a rare neuro-ophthalmologic disease. J Neuroophthalmol. 2000;20(1):61–2.CrossRefPubMedGoogle Scholar
  12. 12.
    Guisset F, Ferreiro C, Voets S, Sellier J, Debaugnies F, Corazza F, Deconinck N, Prigogine C. Anti-GQ1b antibody syndrome presenting as acute isolated bilateral ophthalmoplegia: report on two patients and review of the literature. Euro J Paedi Neurol. 2016;20:439–43.CrossRefGoogle Scholar
  13. 13.
    O’Hanlon GM, Plomp JJ, Chakrabarti M, et al. Anti-GQ1b ganglioside antibodies mediate complement-dependent destruction of the motor nerve terminal. Brain. 2001;124(5):893–906.CrossRefPubMedGoogle Scholar
  14. 14.
    Malhotra A, Zhang M, Wu X, Jindal S, Durand D, Makhani N. MRI findings of optic pathway involvement in Miller Fisher syndrome in 3 pediatric patients and a review of the literature. J Clin Neurosci. 2017;39:63–7.CrossRefPubMedGoogle Scholar
  15. 15.
    Overell JR, Willison HJ. Recent developments in Miller Fisher syndrome and related disorders. Curr Opin Neurol. 2005;18(5):562–6.CrossRefPubMedGoogle Scholar
  16. 16.
    Mori M, Kuwabara S, Fukutake T, et al. Intravenous immunoglobulin therapy for Miller Fisher syndrome. Neurology. 2007;68(14):1144–6.CrossRefPubMedGoogle Scholar
  17. 17.
    Pulitanò S, Viola L, Genovese O, Chiaretti A, Piastra M, Mariotti P, et al. Miller-Fisher syndrome mimicking intracranial hypertension following head trauma. Childs Nerv Syst. 2005;21:473–6.CrossRefPubMedGoogle Scholar
  18. 18.
    Berlit P, Rakicky J. The Miller Fisher syndrome. Review of the literature. J Clin Neuroophthalmol. 1992;12(1):57–63.PubMedGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2018

Authors and Affiliations

  • An-Guor Wang
    • 1
  1. 1.Department of OphthalmologyTaipei Veterans General Hospital, National Yang-Ming University School of Medicine, Yun-San Ophthalmology Education Research FoundationTaipeiTaiwan

Personalised recommendations